-
04-03-2016, 10:44 AM
#14291
Originally Posted by When the bass drops
pierre, is it urine in the blood test? I don't know if the subjects would still be alive in that case haha.
Fellas, You shouldn't be buying this investment if you're looking to make a quick profit inside a year. This is a medium to long-term hold. Have it as part of a wider portfolio.
Its not outside the realms of possibility that Pacific Edge develops a better test, rather than a competitor.
Believe it or not ,I think you are more likely to make a short term gain (from some announcement getting people excited about potential) than a gain in the long term which means they would actually have to be successful and make lots of money and for how long?
-
04-03-2016, 10:48 AM
#14292
Originally Posted by skid
Believe it or not ,I think you are more likely to make a short term gain (from some announcement getting people excited about potential) than a gain in the long term which means they would actually have to be successful and make lots of money and for how long?
You are spot on with your assessment, skid.
That's what the Masfens and the Chairman have done. Hence their decision not to participate in the last capital raising.
-
04-03-2016, 10:54 AM
#14293
Member
I know you probably don't have much patience anymore with these guys, but Balance, lets just wait and see.
-
04-03-2016, 10:58 AM
#14294
Originally Posted by When the bass drops
I know you probably don't have much patience anymore with these guys, but Balance, lets just wait and see.
Please... you wonder why people who are close to the company don't bother posting anymore... they have given up educating people like Balance who have yet to give the company a true chance of commercialisation... they only just finished their sales team and somehow people like balance expect them to have sold millions of tests already, and make claims that the US is in trouble (but then they get VA approval??) and that any price increases (any at all) are only institutions window dressing, among other claims (generally unfounded or unrelated)
It is sad and I'll also say it again: Lets just wait and see (ETA: 1.5 years)
-
04-03-2016, 11:08 AM
#14295
TJ: While I may not always agree with the way that Balance presents his material, he/she is absolutely right. This company has failed to make commercial progress and is on the cusp of being surpassed in terms of product superiority. Once a major player can match/beat PEB's product, it will be total game over. We are 95% of the way there now IMHO.
I saw the writing on the wall a few months ago and sold out for a 6-figure loss. I'm really glad I did, though. Things simply aren't going to get better absent a significant and timely JV with a major player, which I simply cannot see happening.
Best of luck to those that still "believe"
-
04-03-2016, 11:13 AM
#14296
Originally Posted by trader_jackson
Please... you wonder why people who are close to the company don't bother posting anymore... they have given up educating people like Balance who have yet to give the company a true chance of commercialisation... they only just finished their sales team and somehow people like balance expect them to have sold millions of tests already, and make claims that the US is in trouble (but then they get VA approval??) and that any price increases (any at all) are only institutions window dressing, among other claims (generally unfounded or unrelated)
It is sad and I'll also say it again: Lets just wait and see (ETA: 1.5 years)
We have no choice but to wait and see (unless something happens in the meantime) but everyone has a thought on the issue,nay?
PS-what do you mean 'those who are close to the company''--There were a few posters who I wondered if they werent VERY close to the company--now you've got me thinking again
-
04-03-2016, 11:13 AM
#14297
Member
A bit of a wash up
Investors were sold the idea of a high growth company
Their actions and outcomes have not resulted in high growth
Now we talk about "wait and see", "its a med/long term hold"
See the problem....
-
04-03-2016, 11:20 AM
#14298
Originally Posted by OldGuy
TJ: While I may not always agree with the way that Balance presents his material, he/she is absolutely right. This company has failed to make commercial progress and is on the cusp of being surpassed in terms of product superiority. Once a major player can match/beat PEB's product, it will be total game over. We are 95% of the way there now IMHO.
I saw the writing on the wall a few months ago and sold out for a 6-figure loss. I'm really glad I did, though. Things simply aren't going to get better absent a significant and timely JV with a major player, which I simply cannot see happening.
Best of luck to those that still "believe"
its the one thing I always thought was their ace in the hole--''superior product'' but the clock IS ticking...and the ''superior product'' is in the urine testing field which has had a bit of a hit--now they have to convince that the mud shouldnt be sticking to this particular test.
Last edited by skid; 04-03-2016 at 11:25 AM.
-
04-03-2016, 11:34 AM
#14299
Originally Posted by trader_jackson
Please... you wonder why people who are close to the company don't bother posting anymore... they have given up educating people like Balance who have yet to give the company a true chance of commercialisation... they only just finished their sales team and somehow people like balance expect them to have sold millions of tests already, and make claims that the US is in trouble (but then they get VA approval??) and that any price increases (any at all) are only institutions window dressing, among other claims (generally unfounded or unrelated)
It is sad and I'll also say it again: Lets just wait and see (ETA: 1.5 years)
The reason why they don't post anymore is - THEY HAVE RUN OUT OF SPIN.
Recall one who used to write glowing optimistic detailed postings about PEB and deleting them as he went along. Now we know why.
Last edited by Balance; 04-03-2016 at 11:39 AM.
-
04-03-2016, 11:49 AM
#14300
Originally Posted by trader_jackson
...........who have yet to give the company a true chance of commercialisation......
t_j - DD's definition of "successful commercialisation" is bring a product out of the lab into the market. Profit is not a consideration.
He has succeeded admirably in his quest with PEB - just as he did with other successful commercialisations. And shareholders have been rewarded well - the $100m pumped into the company is now worth $173m plus what cash they have left
So task completed - successfully commercialised and the future is really about funding the next discovery
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks